Top

Published in:

01-12-2011 | Editorial

An overview of the European Society of Medical Oncology (ESMO) Symposium on Cancer and Nutrition 2009: from cancer prevention to nutrition support to alleviating suffering in patients with advanced cancer

Authors: Florian Strasser, An Van den Broek, Aminah Jatoi

Published in: Supportive Care in Cancer | Issue 12/2011

Excerpt

The European Society of Medical Oncology Symposium (ESMO) on Cancer and Nutrition convened on March 20–21, 2009, in Zurich, Switzerland. Welcoming 172 participants from 32 countries and from 4 different continents, this symposium was designed to address issues directly relevant to the interface between clinical nutrition and cancer. Was there truly a need for such a conference? The organizers of this meeting contend that the answer is “yes” and cite the following salient examples to show that nutrition really does impact cancer and cancer patients and that focusing a symposium on the interface between nutrition and cancer holds merit. …

ACS webpage: http://www.cancer.org/acs/groups/cid/documents/webcontent/002577-pdf.pdf (last accessed June 2011)

August DA, Huhmann MB (2009) A.S.P.E.N. clinical guidelines: nutrition support therapy during adult anticancer treatment and in hematopoietic cell transplantation. JPEN J Parenter Enteral Nutr 33(5):472–500PubMedCrossRef

Bachmann J, Heiligensetzer M, Krakowski-Roosen H, Büchler MW, Friess H, Martignoni ME (2008) Cachexia worsens prognosis in patients with resectable pancreatic cancer. J Gastrointest Surg 12(7):1193–1201PubMedCrossRef

Blum D, Oberholzer R, Linder S, Hess J, Omlin A, Jurt G, Strasser F (2009) Secondary nutrition impact symptoms: predictors of nutritional intake response to comprehensive nutritional counseling in advanced cancer patients. ESMO Symposium Nutrition and Cancer; Abstract 10PD

Bozzetti F, Arends J, Lundholm K, Micklewright A, Zurcher G, Muscaritoli M, ESPEN (2009) ESPEN guidelines on parenteral nutrition: non-surgical oncology. Clin Nutr 28(4):445–454PubMedCrossRef

Deans DA, Tan BH, Ross JA, Rose-Zerilli M, Wigmore SJ, Howell WM, Grimble RF, Fearon KC (2009) Cancer cachexia is associated with the IL10–1082 gene promoter polymorphism in patients with gastroesophageal malignancy. Am J Clin Nutr 89(4):1164–1172PubMedCrossRef

Evans WJ, Morley JE, Argilés J, Bales C, Baracos V, Guttridge D, Jatoi A, Kalantar-Zadeh K, Lochs H, Mantovani G, Marks D, Mitch WE, Muscaritoli M, Najand A, Ponikowski P, Rossi Fanelli F, Schambelan M, Schols A, Schuster M, Thomas D, Wolfe R, Anker SD (2008) Cachexia: a new definition. Clin Nutr 27(6):793–799PubMedCrossRef

Geels P, Eisenhauer E, Bezjak A, Zee B, Day A (2000) Palliative effect of chemotherapy: objective tumor response is associated with symptom improvement in patients with metastatic breast cancer. J Clin Oncol 18(12):2395–2405PubMed

Hopkinson JB, Wright DN, McDonald JW, Corner JL (2006) The prevalence of concern about weight loss and change in eating habits in people with advanced cancer. J Pain Symptom Manage 32(4):322–331PubMedCrossRef

10.

Huhmann MB, August DA (2008) Review of American Society for Parenteral and Enteral Nutrition (ASPEN) clinical guidelines for nutrition support in cancer patients: nutrition screening and assessment. Nutr Clin Pract 23(2):182–188PubMedCrossRef

11.

Kaasa S, Loge JH, Fayers P, Caraceni A, Strasser F, Hjermstad MJ, Higginson I, Radbruch L, Haugen DF (2008) Symptom assessment in palliative care: a need for international collaboration. J Clin Oncol 26(23):3867–3873PubMedCrossRef

12.

Koeberle D, Saletti P, Borner M, Gerber D, Dietrich D, Caspar CB, Mingrone W, Beretta K, Strasser F, Ruhstaller T, Mora O, Herrmann R, Swiss Group for Clinical Cancer Research (2008) Patient-reported outcomes of patients with advanced biliary tract cancers receiving gemcitabine plus capecitabine: a multicenter, phase II trial of the Swiss Group for Clinical Cancer Research. J Clin Oncol 26(22):3702–3708PubMedCrossRef

13.

Mantovani G, Madeddu C, Gramignano G, Serpe R, Massa E, Deiana L, Macciò A (2007) An innovative treatment approach for cancer-related anorexia/cachexia and oxidative stress: background and design of an ongoing, phase III, randomized clinical trial. Support Cancer Ther 4(3):163–167PubMedCrossRef

14.

Meyerhardt JA, Tepper JE, Niedzwiecki D, Hollis DR, McCollum AD, Brady D, O’Connell MJ, Mayer RJ, Cummings B, Willett C, Macdonald JS, Benson AB 3rd, Fuchs CS (2004) Impact of body mass index on outcomes and treatment-related toxicity in patients with stage II and III rectal cancer: findings from Intergroup Trial 0114. J Clin Oncol 22(4):648–657PubMedCrossRef

15.

Miller P, Demark-Wahnefried W, Snyder DC, Sloane R, Morey MC, Cohen H, Kranz S, Mitchell DC, Hartman TJ (2006) Dietary supplement use among elderly, long-term cancer survivors. J Cancer Surviv 2(3):138–148CrossRef

16.

Ohno T, Kato S, Wakatsuki M, Noda SE, Murakami C, Nakamura M, Tsujii H (2006) Incidence and temporal pattern of anorexia, diarrhea, weight loss, and leukopenia in patients with cervical cancer treated with concurrent radiation therapy and weekly cisplatin: comparison with radiation therapy alone. Gynecol Oncol 103(1):94–99PubMedCrossRef

17.

Omenn GS, Goodman GE, Thornquist MD, Balmes J, Cullen MR, Glass A, Keogh JP, Meyskens FL, Valanis B, Williams JH, Barnhart S, Hammar S (1996) Effects of a combination of beta carotene and vitamin A on lung cancer and cardiovascular disease. N Engl J Med 334(18):1150–1155PubMedCrossRef

18.

Orrevall Y, Tishelman C, Permert J, Cederholm T (2009) Nutritional support and risk status among cancer patients in palliative home care services. Support Care Cancer 17(2):153–161PubMedCrossRef

19.

Pacelli F, Bossola M, Rosa F, Tortorelli AP, Papa V, Doglietto GB (2008) Is malnutrition still a risk factor of postoperative complications in gastric cancer surgery? Clin Nutr 27(3):398–407PubMedCrossRef

20.

Ravasco P, Monteiro Grillo I, Camilo M (2007) Cancer wasting and quality of life react to early individualized nutritional counselling! Clin Nutr 26(1):7–15PubMedCrossRef

21.

Satia JA, Littman A, Slatore CG, Galanko JA, White E (2009) Long-term use of beta-carotene, retinol, lycopene, and lutein supplements and lung cancer risk: results from the VITamins And Lifestyle (VITAL) study. Am J Epidemiol 169(7):815–828PubMedCrossRef

22.

Sharma R, Singh DP, Sharma OP, Sharma S (2009) Improvement of nutritional status in advanced head and neck cancer patients. ESMO Symposium Nutrition and Cancer; Abstract 17PD

23.

Tewari N, Martin-Ucar AE, Black E, Beggs L, Beggs FD, Duffy JP, Morgan WE (2007) Nutritional status affects long term survival after lobectomy for lung cancer. Lung Cancer 57(3):389–394PubMedCrossRef

24.

van den Berg MG, Rasmussen-Conrad EL, Gwasara GM, Krabbe PF, Naber AH, Merkx MA (2006) A prospective study on weight loss and energy intake in patients with head and neck cancer, during diagnosis, treatment and revalidation. Clin Nutr 25(5):765–772PubMedCrossRef

25.

van Norren K, van Helvoort A, Argilés JM, van Tuijl S, Arts K, Gorselink M, Laviano A, Kegler D, Haagsman HP, van der Beek EM (2009) Direct effects of doxorubicin on skeletal muscle contribute to fatigue. Br J Cancer 100(2):311–314PubMedCrossRef

26.

van Norren K, Kegler D, Argilés JM, Luiking Y, Gorselink M, Laviano A, Arts K, Faber J, Jansen H, van der Beek EM, van Helvoort A (2009) Dietary supplementation with a specific combination of high protein, leucine, and fish oil improves muscle function and daily activity in tumour-bearing cachectic mice. Br J Cancer 100(5):713–722PubMedCrossRef

27.

Velicer CM, Ulrich CM (2008) Vitamin and mineral supplement use among US adults after cancer diagnosis: a systematic review. J Clin Oncol 26(4):665–673PubMedCrossRef

Title: An overview of the European Society of Medical Oncology (ESMO) Symposium on Cancer and Nutrition 2009: from cancer prevention to nutrition support to alleviating suffering in patients with advanced cancer
Authors: Florian Strasser
An Van den Broek
Aminah Jatoi
Publication date: 01-12-2011
Publisher: Springer-Verlag
Published in: Supportive Care in Cancer / Issue 12/2011
Print ISSN: 0941-4355
Electronic ISSN: 1433-7339
DOI: https://doi.org/10.1007/s00520-011-1246-1

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras

Prof. Fabrice Barlesi

Developed by: Springer Medicine

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 12/2011

RANK ligand inhibition in bone metastatic cancer and risk of osteonecrosis of the jaw (ONJ): non bis in idem?

Predictors of existential and religious well-being among cancer patients

Effect of eszopiclone on sleep, fatigue, and pain in patients with mucositis associated with hematologic malignancies

Comprehensive needs assessment tool in cancer (CNAT): the development and validation

Breakthrough pain: a qualitative study involving patients with advanced cancer

Complementary therapy and support services for formal and informal caregivers in Italian palliative care hospices: an exploratory and descriptive study

Keynote webinar | Spotlight on antibody–drug conjugates in cancer